FDA approves new Alzheimer’s blood test
FDA approves new Alzheimer’s blood test American Hospital Association
August 2026
FDA Approves Ziihera Regimens in First-Line HER2+ Advanced GEA
FDA Approves Ziihera Regimens in First-Line HER2+ Advanced GEA Oncology Nursing News
FDA Approves Zanidatamab Combination Regimens for HER2 Gastric GEJ or Esophageal Cancer
FDA Approves Zanidatamab Combination Regimens for HER2 Gastric GEJ or Esophageal Cancer The ASCO Post
Behind the FDA Approval: ‘Historic’ Iberdomide Trial Spotlights MRD End Point and Potential of CELMoDs Across Myeloma
Behind the FDA Approval: ‘Historic’ Iberdomide Trial Spotlights MRD End Point and Potential of CELMoDs Across Myeloma Targeted Oncology
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Locally Advanced or Metastatic Gastric Cancer
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Locally Advanced or Metastatic Gastric Cancer OncLive